Astrana Health
ASTH
32 hedge funds and large institutions have $67.5M invested in Astrana Health in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 7 closing their positions.
681% more capital invested
Capital invested by funds: $8.64M → $67.5M (+$58.9M)
271% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 7
146% more funds holding
Funds holding: 13 → 32 (+19)
6.35% more ownership
Funds ownership: 1.48% → 7.83% (+6.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$18.7M |
| 2 |
State Street
Boston,
Massachusetts
|
+$5.92M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.59M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$4.07M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.28M |
| 2 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$928K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$645K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$416K |
| 5 |
Man Group
London,
United Kingdom
|
-$416K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $90K | +$22.9K | +1,334 | +62% |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $61K | +$360 | +21 | +0.9% |
|
|
AIP
28
Ameritas Investment Partners
Lincoln,
Nebraska
| $53K | +$35.4K | +2,066 | New |
|
29
Barclays
London,
United Kingdom
| $48K | +$32.1K | +1,874 | New |
|
30
BNP Paribas Financial Markets
Paris,
France
| $20.9K | +$13.9K | +810 | New |
|
|
PIA
31
Piedmont Investment Advisors
Durham,
North Carolina
| $11K | +$7.37K | +430 | New |
|
32
Bank of Montreal
Toronto,
Ontario, Canada
| $5K | +$3.02K | +176 | New |
|
|
33
Millennium Management
New York
| – | -$5.28M | -330,797 | Closed |
|
|
TEE
34
Tibra Equities Europe
London,
United Kingdom
| – | -$928K | -58,180 | Closed |
|
|
35
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$645K | -40,449 | Closed |
|
|
CS
36
Credit Suisse
Zurich,
Switzerland
| – | -$416K | -26,086 | Closed |
|
|
37
Man Group
London,
United Kingdom
| – | -$416K | -26,086 | Closed |
|
38
Goldman Sachs
New York
| – | -$211K | -13,219 | Closed |
|
|
RA
39
Royce & Associates
New York
| – | -$3K | -208 | Closed |
|
ASTH Hedge Fund Activity: Q2 2018 in Review
32 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q2 2018, worth a combined $67.5M — up 681% from $8.64M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ASTH positions and 7 closed out — a net gain of 19 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $18.7M. The largest seller was Millennium Management, exiting entirely with an estimated $5.28M sold.
- 32 institutional investors held Astrana Health (ASTH) as of Q2 2018, up from 13 in Q1 2018.
- Funds reported $67.5M of Astrana Health stock for Q2 2018, up 681% quarter-over-quarter.
- 26 funds opened new Astrana Health positions in Q2 2018 and 7 closed out, a net change of +19 holders.
- The largest Astrana Health buyer in Q2 2018 was BlackRock, an estimated $18.7M added.
- The largest Astrana Health seller in Q2 2018 was Millennium Management, an estimated $5.28M sold.
Based on aggregated 13F filings for Q2 2018.